C9094 Inj, sutimlimab-jome, 10 mg

⚠ Terminated HCPCS Level II 2026
Terminated Code
C9094 was terminated as of 2022-09-30 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open C9094 in the app →

Look up C9094 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

C9094 is the HCPCS Level II code for Inj, sutimlimab-jome, 10 mg (2026). It belongs to Section C — Outpatient PPS (Hospital). Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Statute.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Statute (indicator 53)
Type of Service
Medical care
Effective Date
2022-10-01
Termination Date
2022-09-30
2026 Maintenance
No change this year

References

Cite This Page

Reference C9094 with the canonical source and edition:

C9094 — Inj, sutimlimab-jome, 10 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/C9094

Canonical URL: https://icd10codingpro.com/hcpcs-codes/C9094

Related Codes in Section C

← C9093 Inj., susvimo, 0.1 mg C9095 → Inj, tebentafusp-tebn, 1 mcg
C9090 Plasminogen, human-tvmh 1 mg C9091 Sirolimus, protein-bound,1mg C9092 Inj., xipere, 1 mg C9093 Inj., susvimo, 0.1 mg C9095 Inj, tebentafusp-tebn, 1 mcg C9096 Inj, releuko, 1 mcg C9097 Inj, faricimab-svoa, 0.1 mg C9098 Ciltacabtagene car pos t C9101 Inj, oliceridine 0.1 mg C9113 Inj pantoprazole sodium, via
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial